Neonatal sepsis

The Lancet

Volumn 390, Issue 10104, 2017, Pages 1770-1780

  Shane, Andi L ^a   Sánchez, Pablo J ^b   Stoll, Barbara J ^c  

^a CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; CHILD PARENT RELATION; DISEASE BURDEN; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HIGH RISK INFANT; HUMAN; INCIDENCE; INFECTION RISK; LENGTH OF STAY; LISTERIA MONOCYTOGENES; NEWBORN; NEWBORN MORBIDITY; NEWBORN MORTALITY; NEWBORN SEPSIS; NONHUMAN; ONSET AGE; PATHOPHYSIOLOGY; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; STREPTOCOCCUS AGALACTIAE; ALGORITHM; BLOOD COMPONENT THERAPY; CHORIOAMNIONITIS; COMPLICATION; CROSS INFECTION; FEMALE; GRANULOCYTE; PREGNANCY; PRENATAL EXPOSURE;

ANTIINFECTIVE AGENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; PENTOXIFYLLINE; SCAVENGER;

ALGORITHMS; ANTI-INFECTIVE AGENTS; BLOOD COMPONENT TRANSFUSION; CHORIOAMNIONITIS; CROSS INFECTION; FEMALE; FREE RADICAL SCAVENGERS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GRANULOCYTES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; NEONATAL SEPSIS; PENTOXIFYLLINE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS;

EID: 85018661717     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)31002-4     Document Type: Review

References (64)

1. Wynn, JL, Wong, HR, Shanley, TP, Bizzarro, MJ, Saiman, L, Polin, RA, Time for a neonatal-specific consensus definition for sepsis. Pediatr Crit Care Med 15 (2014), 523–528.
2. van den Hoogen, A, Gerards, LJ, Verboon-Maciolek, MA, Fleer, A, Krediet, TG, Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents. Neonatology 97 (2010), 22–28.
3. Stoll, BJ, Hansen, NI, Sanchez, PJ, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 127 (2011), 817–826.
4. Lukacs, SL, Schrag, SJ, Clinical sepsis in neonates and young infants, United States, 1988–2006. J Pediatr 160 (2012), 960–965.
5. Sgro, M, Shah, PS, Campbell, D, et al. Early-onset neonatal sepsis: rate and organism pattern between 2003 and 2008. J Perinatol 31 (2011), 794–798.
6. Rampersaud, R, Randis, TM, Ratner, AJ, Microbiota of the upper and lower genital tract. Semin Fetal Neonatal Med 17 (2012), 51–57.
7. Read, JS, Cannon, MJ, Stanberry, LR, Schuval, S, Prevention of mother-to-child transmission of viral infections. Curr Probl Pediatr Adolesc Health Care 38 (2008), 274–297.
8. Wortham, JM, Hansen, NI, Schrag, SJ, et al. Chorioamnionitis and culture-confirmed, early-onset neonatal infections. Pediatrics, 137, 2016, e20152323.
9. Buhimschi, CS, Bhandari, V, Dulay, AT, et al. Proteomics mapping of cord blood identifies haptoglobin “switch-on” pattern as biomarker of early-onset neonatal sepsis in preterm newborns. PLoS One, 6, 2011, e26111.
10. Galinsky, R, Polglase, GR, Hooper, SB, Black, MJ, Moss, TJ, The consequences of chorioamnionitis: preterm birth and effects on development. J Pregnancy, 2013, 2013, 412831.
11. Goldenberg, NM, Steinberg, BE, Slutsky, AS, Lee, WL, Broken barriers: a new take on sepsis pathogenesis. Sci Transl Med, 3, 2011, 88ps25.
12. Higgins, RD, Saade, G, Polin, RA, et al. Evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis: summary of a workshop. Obstet Gynecol 127 (2016), 426–436.
13. Bizzarro, MJ, Jiang, Y, Hussain, N, Gruen, JR, Bhandari, V, Zhang, H, The impact of environmental and genetic factors on neonatal late-onset sepsis. J Pediatr 158 (2011), 234–238.
14. Verani, JR, McGee, L, Schrag, SJ, Division of bacterial diseases NCfI, respiratory diseases CfDC, prevention, prevention of perinatal group B streptococcal disease—revised guidelines from CDC, 2010. MMWR Recomm Rep 59 (2010), 1–36.
15. Kaufman, DA, Coggins, SA, Zanelli, SA, Weitkamp, JH, Congenital cutaneous candidiasis: prompt systemic treatment is associated with improved outcomes in neonates. Clin Infect Dis, 2017, 10.1093/cid/cix119 published online Feb 4.
16. Barton, M, Shen, A, O'Brien, K, et al. Early onset invasive candidiasis in extremely low birthweight infants: perinatal acquisition predicts poor outcome. Clin Infect Dis, 2017, 10.1093/cid/cix001 published online Jan 11.
17. Lee, B, Newland, JG, Jhaveri, R, Reductions in neonatal listeriosis: “Collateral benefit” of group B streptococcal prophylaxis?. J Infect 72 (2016), 317–323.
18. Bizzarro, MJ, Shabanova, V, Baltimore, RS, Dembry, LM, Ehrenkranz, RA, Gallagher, PG, Neonatal sepsis 2004–2013: the rise and fall of coagulase-negative staphylococci. J Pediatr 166 (2015), 1193–1199.
19. Dong, Y, Speer, CP, The role of Staphylococcus epidermidis in neonatal sepsis: guarding angel or pathogenic devil?. Int J Med Microbiol 304 (2014), 513–520.
20. Jean-Baptiste, N, Benjamin, DK Jr., Cohen-Wolkowiez, M, et al. Coagulase-negative staphylococcal infections in the neonatal intensive care unit. Infect Control Hosp Epidemiol 32 (2011), 679–686.
21. Marchant, EA, Boyce, GK, Sadarangani, M, Lavoie, PM, Neonatal sepsis due to coagulase-negative staphylococci. Clin Dev Immunol, 2013, 2013, 586076.
22. Vergnano, S, Menson, E, Smith, Z, et al. Characteristics of invasive Staphylococcus aureus in United Kingdom neonatal units. Pediatr Infect Dis J 30 (2011), 850–854.
23. Investigators of the Delhi Neonatal Infection Study (DeNIS) collaboration. Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study. Lancet Glob Health 4 (2016), e752–e760.
24. Gnann, JW Jr, Whitley, RJ, Genital herpes. N Engl J Med, 375, 2016, 1906.
25. Kimberlin, DW, Whitley, RJ, Wan, W, et al. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med 365 (2011), 1284–1292.
26. Thompson, C, Whitley, R, Neonatal herpes simplex virus infections: where are we now?. Adv Exp Med Biol 697 (2011), 221–230.
27. Khetsuriani, N, Lamonte, A, Oberste, MS, Pallansch, M, Neonatal enterovirus infections reported to the national enterovirus surveillance system in the United States, 1983–2003. Pediatr Infect Dis J 25 (2006), 889–893.
28. Modlin, JF, Treatment of neonatal enterovirus infections. J Pediatric Infect Dis Soc 5 (2016), 63–64.
29. Verboon-Maciolek, MA, Krediet, TG, Gerards, LJ, de Vries, LS, Groenendaal, F, van Loon, AM, Severe neonatal parechovirus infection and similarity with enterovirus infection. Pediatr Infect Dis J 27 (2008), 241–245.
30. Trofa, D, Gácser, A, Nosanchuk, JD, Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 21 (2008), 606–625.
31. Pammi, M, Holland, L, Butler, G, Gacser, A, Bliss, JM, Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis. Pediatr Infect Dis J 32 (2013), e206–e216.
32. Benjamin, DK Jr, Stoll, BJ, Gantz, MG, et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics 126 (2010), e865–e873.
33. Cetinkaya, M, Cekmez, F, Buyukkale, G, et al. Lower vitamin D levels are associated with increased risk of early-onset neonatal sepsis in term infants. J Perinatol 35 (2015), 39–45.
34. Stoll, BJ, Shame, AL, Infections of the neonatal infant. Kliegman, R, Stanton, B, St Geme, J, Schor, N, (eds.) Nelson Textbook of Pediatrics, 20th edn., 2015, Elsevier, Philadelphia, 909–925.
35. WHO. WHO guidelines on drawing blood: best practices in phlebotomy. http://apps.who.int/iris/bitstream/10665/44294/1/9789241599221_eng.pdf, 2010 (accessed April 18, 2017).
36. Stoll, BJ, Hansen, N, Fanaroff, AA, et al. To tap or not to tap: high likelihood of meningitis without sepsis among very low birth weight infants. Pediatrics 113 (2004), 1181–1186.
37. Malcolmson, C, Ng, K, Hughes, S, et al. Impact of matrix-assisted laser desorption and ionization time-of-flight and antimicrobial stewardship intervention on treatment of bloodstream infections in hospitalized children. J Pediatric Infect Dis Soc, 2016, 10.1093/jpids/piw033 published online June 23.
38. Salimnia, H, Fairfax, MR, Lephart, PR, et al. Evaluation of the filmarray blood culture identification panel: results of a multicenter controlled trial. J Clin Microbiol 54 (2016), 687–698.
39. Arora, HS, Asmar, BI, Salimnia, H, Agarwal, P, Chawla, S, Abdel-Haq, N, Enhanced identification of group B Streptococcus and Escherichia coli in young infants with meningitis using the biofire filmarray meningitis/encephalitis panel. Pediatr Infect Dis J, 2017, 10.1097/INF.0000000000001551 published online Jan 19.
40. Ruangkit, C, Satpute, A, Vogt, BA, Hoyen, C, Viswanathan, S, Incidence and risk factors of urinary tract infection in very low birth weight infants. J Neonatal Perinatal Med 9 (2016), 83–90.
41. Benitz, WE, Adjunct laboratory tests in the diagnosis of early-onset neonatal sepsis. Clin Perinatol 37 (2010), 421–438.
42. 2. Pediatr Infect Dis 33 (2014), 798–802.
43. Newman, TB, Draper, D, Puopolo, KM, Wi, S, Escobar, GJ, Combining immature and total neutrophil counts to predict early onset sepsis in term and late preterm newborns: use of the I/T2. Pediatr Infect Dis J 33 (2014), 798–802.
44. Jackson, GL, Engle, WD, Sendelbach, DM, et al. Are complete blood cell counts useful in the evaluation of asymptomatic neonates exposed to suspected chorioamnionitis?. Pediatrics 113 (2004), 1173–1180.
45. Mikhael, M, Brown, LS, Rosenfeld, CR, Serial neutrophil values facilitate predicting the absence of neonatal early-onset sepsis. J Pediatr 164 (2014), 522–528.
46. Pugni, L, Pietrasanta, C, Milani, S, et al. Presepsin (soluble CD14 subtype): reference ranges of a new sepsis marker in term and preterm neonates. PLoS One, 10, 2015, e0146020.
47. Mussap, M, Puxeddu, E, Puddu, M, et al. Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS. Clin Chim Acta 451 (2015), 65–70.
48. Hofer, N, Zacharias, E, Muller, W, Resch, B, An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology 102 (2012), 25–36.
49. Bhandari, V, Effective biomarkers for diagnosis of neonatal sepsis. J Pediatric Infect Dis Soc 3 (2014), 234–245.
50. Lutsar, I, Chazallon, C, Carducci, FI, et al. Current management of late onset neonatal bacterial sepsis in five European countries. Eur J Pediatr 173 (2014), 997–1004.
51. Escobar, GJ, Puopolo, KM, Wi, S, et al. Stratification of risk of early-onset sepsis in newborns ≥34 weeks' gestation. Pediatrics 133 (2014), 30–36.
52. Puopolo, KM, Draper, D, Wi, S, et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatrics 128 (2011), e1155–e1163.
53. Sullins, AK, Abdel-Rahman, SM, Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. Paediatr Drugs 15 (2013), 93–117.
54. Castagnola, E, Dufour, C, Role of G-CSF GM-CSF in the management of infections in preterm newborns: an update. Early Hum Dev 90:suppl 2 (2014), S15–S17.
55. Carr, R, Brocklehurst, P, Dore, CJ, Modi, N, Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial. Lancet 373 (2009), 226–233.
56. Ohlsson, A, Lacy, J, Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev, 3, 2010 CD001239.
57. Manzoni, P, Decembrino, L, Stolfi, I, et al. Lactoferrin and prevention of late-onset sepsis in the pre-term neonates. Early Hum Dev 86:suppl 1 (2010), 59–61.
58. Sanchez, PJ, Moallem, M, Cantey, JB, Milton, A, Michelow, IC, Empiric therapy with vancomycin in the neonatal intensive care unit: let's “get smart” globally!. J Pediatr (Rio J) 92 (2016), 432–435.
59. Chiu, CH, Michelow, IC, Cronin, J, Ringer, SA, Ferris, TG, Puopolo, KM, Effectiveness of a guideline to reduce vancomycin use in the neonatal intensive care unit. Pediatr Infect Dis J 30 (2011), 273–278.
60. Greenwood, C, Morrow, AL, Lagomarcino, AJ, et al. Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter. J Pediatr 165 (2014), 23–29.
61. Marlow, N, Morris, T, Brocklehurst, P, et al. A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: childhood outcomes at 5 years. Arch Dis Child Fetal Neonatal Ed 100 (2015), F320–F326.
62. Mathias, B, Szpila, BE, Moore, FA, Efron, PA, Moldawer, LL, A review of GM-CSF therapy in sepsis. Medicine (Baltimore), 94, 2015, e2044.
63. INIS Collaborative Group, Brocklehurst, P, Farrell, B, et al. Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med 365 (2011), 1201–1211.
64. Haque, KN, Pammi, M, Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates. Cochrane Database Syst Rev, 10, 2011 CD004205.